TIMP1 and glioma: Furthermore, highly expressed TIMP1 can be recognized as an independent prognostic biomarker, as the p-value of overall survival (OS) was 0.007 and the p-value of diseasE−free survival (DFS) was less than 0.0001 in glioma patients (Fig. 5B).